Page last updated: 2024-11-08

desoxycorticosterone acetate and Glomerulosclerosis, Focal Segmental

desoxycorticosterone acetate has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies

Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.

Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Toba, H1
Ikemoto, MJ1
Kobara, M1
Nakata, T1

Other Studies

1 other study available for desoxycorticosterone acetate and Glomerulosclerosis, Focal Segmental

ArticleYear
Secreted protein acidic and rich in cysteine (SPARC) and a disintegrin and metalloproteinase with thrombospondin type 1 motif (ADAMTS1) increments by the renin-angiotensin system induce renal fibrosis in deoxycorticosterone acetate-salt hypertensive rats.
    European journal of pharmacology, 2022, Jan-05, Volume: 914

    Topics: ADAMTS1 Protein; Angiotensin II Type 1 Receptor Blockers; Animals; Desoxycorticosterone Acetate; Ext

2022